Aberrant FASN expression disrupts fatty acid metabolic homeostasis, triggers lipid dysmetabolism, and contributes to pathological processes including tumor proliferation and energy reprogramming by supplying abnormal lipid substrates, thereby impacting metabolic microenvironmental homeostasis [30]. The gene discussed is FASN; the disease is neoplasm.